Dispatches from Vitafoods

Moving towards a cranberry PACs pact

This content item was originally published on NutraIngredients.com, a William Reed online publication.

Julie Rosenborg, from Lallemand Health Ingredients, and Diana Naturals' Mathieu Besnard spoke with Shane Starling about some of the issues surrounding the proanthocyanidin content of cranberry and how the French urinary tract infection health claim passed in 2004 has influenced scientific development and the market.

They discuss how the level of 36mg of PACs specified as an efficacious dose in the French claim has been both a boon and a bane.

Differing methods of PACs measurement are also discussed and how they feed into notions of efficaciousness.